Competitor News – Page 94 – Healthcare Data News

Foundation Medicine’s ctDNA Monitoring Assay, FoundationOne®Tracker, Granted Breakthrough Device Designation by U.S. Food and Drug Administration

February 15, 2022 06:56 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc., a pioneer in molecular profiling for cancer, today announced that the U.S. Food and Drug Administration (FDA)...

February 15, 2022February 21, 2022 AI Competitor News Oncology

AI & cancer: Big data, big gains for medicine

Orlando Agrippa, CEO and Founder of RwHealth, turns the spotlight on AI and cancer, where big data brings big gains for medicine The words artificial intelligence (AI) and ‘machine learning’ (ML) are likely familiar to...

February 15, 2022February 21, 2022 Collaborations Competitor News Data Partnership

Generating real-world data from health records: design of a patient-centric study in multiple sclerosis using a commercial health records platform

ABSTRACT OBJECTIVE: The FlywheelMS study will explore the use of a real-world health record data set generated by PicnicHealth, a patient-centric health records platform, to improve understanding of disease course...

February 14, 2022February 21, 2022 Clinical Trials Competitor News HR

Curebase Adds Two Clinical Trial Veterans to Kick-off New Advisory Board

SAN FRANCISCO, Feb. 14, 2022 /PRNewswire/ — Curebase, a company committed to democratizing access to clinical studies, has named Dr. Aaron Kamauu and Dr. Amir Lahav to the Curebase Advisory Board. The new board members will help...

February 11, 2022February 15, 2022 Clinical Trials Competitor News

Radicle Science Makes History Again With First Large-Scale Clinical Trials on Rare Cannabinoids, Including THCV, CBN, CBG, and CBC

Radicle Science launches several blinded placebo-controlled clinical trials on rare cannabinoids with 10,000 participants in the first half of 2022 on the heels of completing 25 large-scale CBD studies in...

February 9, 2022February 14, 2022 Collaborations Competitor News Oncology Pharma

Foundation Medicine Announces Global Collaboration With Lilly to Develop FoundationOne®CDx and FoundationOne®Liquid CDx as Companion Diagnostics for RETEVMO® and Loxo Oncology at Lilly’s Pipeline Programs

February 09, 2022 06:55 AM Eastern Standard Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. today announced a collaboration with Eli Lilly and Company (Lilly) for the development of Foundation Medicine’s tissue- and...

February 8, 2022February 14, 2022 Competitor News M&A Oncology

Tempus Announces the Acquisition of Highline Sciences

Tempus Announces the Acquisition of Highline Sciences February 08, 2022 08:00 AM Eastern Standard Time CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced the acquisition of...

February 8, 2022February 14, 2022 Collaborations Competitor News COVID-19

Vault Health Partners with Datavant to Enable Connectivity to Millions of COVID-19 Test Results and Unlock Pandemic Insights

SAN FRANCISCO, Feb. 8, 2022 /PRNewswire/ — Vault Health, a national leader in remote diagnostics and COVID testing, and Datavant, the leader in helping organizations securely de-identify and connect health data, today announced...

February 8, 2022February 14, 2022 Collaborations Competitor News Data Partnership

New Benchmark Report from NIST, Baylor College of Medicine and DNAnexus Helps Provide Accurate Identification of Variants in Challenging Medically Relevant Genes

New Nature Biotechnology publication advances efforts to improve genome sequencing information for diagnosis and treatment of diseaseFebruary 08, 2022 08:03 AM Eastern Standard Time MOUNTAIN VIEW, Calif. & HOUSTON–(BUSINESS WIRE)–Researchers from National Institute...

February 8, 2022February 14, 2022 Competitor News

Prognos Health Named to NYC Digital Health 100 by NYCHBL

Real world data and platform company recognized among the most innovative digital health companies in the New York region dedicated to improving health outcomesFebruary 08, 2022 10:35 AM Eastern Standard...